R&D | March 20, 2026
NIPER Raebareli–Roche tie-up signals big push for India’s pharma innovation future
The partnership is designed to close the gap between classroom learning and real-world pharmaceutical practice
The partnership is designed to close the gap between classroom learning and real-world pharmaceutical practice
The move opens Japan’s advanced life science market to Epigenica’s high-throughput epigenetic profiling kits
The planned facility, to be built at Samsung’s Bio Campus II, is set to become a launchpad for up to 30 emerging biotech firms
Desidustat tablets are a novel oral HIF-PHI approved for treating anaemia in non-dialysis adult CKD patients
The move comes as China rapidly expands its capabilities in the pharmaceutical sector, particularly in licensing and drug development
The acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth
The new equipment will be installed at Codis’ 400,000-square-foot Haverhill facility and is expected to be operational by 2027
The initiative provides clearer regulatory guidance and a defined path from research in space to patient access on Earth
Subscribe To Our Newsletter & Stay Updated
